Anti-obesity medication Acomplia for weight loss
Acomplia is an anti-obesity narcotic manufactured by Sanofi Aventis. It is used to support stout and overweight patients with associated risk factors of elevated diabetes or great cholesterol lose weight. Acomplia is approved for employ within the European Union and has been available to patients in the UK owing to Jun 2006. This anti-obesity medicine is even to be approved by the FDA for the US.
About Acomplia
If you require to apprehend how Acomplia helps in weight loss, the later explanation testament advice you out.
Acomplia as an anti-obesity medicine works by blocking receptors called cannabinoid-1 receptors (CB1). These receptors are form in distinct parts of the object such as in the brain, fat tissue, digestive system, liver, and muscles. When these receptors are over activated, they example to an enlargement in appetite, cravings for chow and fat build-up.
Acomplia blocks these CB1 receptors and leads to a shorten in appetite, and allows you to authority famine which consequently results in convincing weight loss.
Strength and Ingredients of Acomplia
Acomplia contains rimonabant as it active ingredient, which is a type of medicine hackneyed as a cannabinoid-1 receptor antagonist and works as an appetite suppressant. This anti-obesity medicine is available in 10mg and 20mg dosage and is to be taken as prescribed by the doctor.
Side tool of Acomplia
There are bare infrequent side item of Acomplia and they are impermanent and transient in nature. Some of the side part of this anti-obesity medication allow for nausea, dizziness, diarrhoea, vomiting, hypoglycaemia, anxiety, and temper swings.
Online availability of Acomplia
Provided you wish to impress Acomplia online nevertheless are not confident whether you will bend it or not, scan on. Most humans can shop for this anti-obesity medicine without any problem. However, if you obtain decided medical conditions since of which Acomplia becomes unsafe for you, you will not be able to move it online or offline.
If you are overweight i.e. your BMI is over 30, or are overweight and your BMI is between 27 and 30 and you are at risk of medical conditions related to weight or item fat, such as diabetes, eminent cholesterol, or hypertension, you can carry Acomplia prescription online.
If you applicable any of the closest criteria, you will not bias Acomplia online :
- over 75 dotage of age
- decreased liver function
- decreased kidney function
- had a love encroachment or stroke in the remain six months
- chronicle of depression or suicidal thoughts
- epilepsy
- allergy to rimonabant or any other ingredient of Acomplia
- Severely decreased liver and/or kidney function
- Uncontrolled determined psychiatric illness
- Large-scale depressive illness
- Cats captivating antidepressant medicines
- Pregnancy
- Breastfeeding
Autor: Katie Lynn Webmaster associated with online pharmacy "OnlineClinic.co.uk" this site provides information about Acomplia & Obesity. Buy Acompla the Weight loss Drug for Obesity treatment.
Source: http://articlebiz.com/article/222803-1-anti-obesity-medicati~
Added: September 19, 2008
Source: http://articlebiz.com/article/222803-1-anti-obesity-medicati~
Added: September 19, 2008
Last relative articles:
- How To Lose Weight For Teens
- Ladies, These Three Secrets Testament Cooperate You Lose Weight Quickly
- Overcoming Weight Loss Plateau In 2 Ways
- Getting Complimentary Material Approximately Weight Loss
- How to Consider Yourself Determine - Correct Custom of Your Most Helpful Weight Loss Item - Your Brain
- Weight Loss Supplements - 4 Complete s and Don ts You Should Pursue Strictly
- Minerals For Weight Loss
- Is Fasting Sheltered for Fleeting Weight Loss?
- The Skinny on Weight Loss
- Weight Loss Supplements
30 Nov 2008 23:00:27
New Sanofi CEO Expected to Map Fresh Course on Developing Drugs - Wall Street Journal
New Sanofi CEO Expected to Map Fresh Course on Developing Drugs Wall Street Journal - One example: the obesity pill Acomplia , which Sanofi continued to develop years after signs emerged that the drug had negative psychological side effects. ... Viehbachers First Day On The Job At Sanofi Viehbacher, Passed Over at Glaxo, Takes Sanofi Reins (Update1) What will Viehbacher bring to Sanofi?
More details: http://online.wsj.com/article/SB122807657188167211.html
27 Nov 2008 08:36:16
Anti-obesity agent Acomplia is withdrawn - Healthcare Republic
Anti-obesity agent Acomplia is withdrawn Healthcare Republic - The marketing authorisation for Acomplia (rimonabant) has been suspended after a European Medicines Agency (EMEA) review. The EMEA's Committee for Medicinal ...
17 Nov 2008 11:12:53
UPDATE 1-Solvay ends research on obesity drug - Reuters
UPDATE 1-Solvay ends research on obesity drug Reuters - Acomplia , which led the field, had already been withdrawn from the European market last month after being linked to mental disorders. ...
17 Nov 2008 05:14:21
Solvay discontinues research into potential obesity compound - Hays Pharma
Pharma Times (registration) Solvay discontinues research into potential obesity compound Hays Pharma, UK - The company's investigational compound SLV319 was in phase-two development and, according to the company, recent results had "confirmed its clinical ... Tough regulatory climate sees Solvay end trials of SLV31913 Nov 2008 21:17:07
Firm stops trials of obesity drug - Healthcare Republic
Firm stops trials of obesity drug Healthcare Republic - Sanofi-Aventis has discontinued all trials of its anti-obesity drug rimonabant ( Acomplia ), which was suspended by the European Medicines Agency last month. ...
13 Nov 2008 11:03:00
Development of rimonabant and CP-945598 for obesity is discontinued - Drug Topics Magazine
Development of rimonabant and CP-945598 for obesity is discontinued Drug Topics Magazine, NJ - ... European marketing authorization of rimonabant (European brand name Acomplia ) be suspended because of an increased risk of psychiatric adverse events. ...
07 Nov 2008 05:45:55
Competitor Analysis: Cannabinoid CB1 Receptor Antagonists - Out Now - MarketWatch
Competitor Analysis: Cannabinoid CB1 Receptor Antagonists - Out Now MarketWatch - Acomplia (rimonabant) from Sanofi-Aventis is the only representative of this class of CB1 antagonists so far approved. While the FDA rejected approval due ...
Keywords:
acomplia,
medication acomplia,
acomplia weight,
loss acomplia,
acomplia prescription,
acomplia bare,
acomplia dotage,
acomplia unsafe,
acomplia nevertheless,
acomplia acomplia